Interestingly, most (up to 86%) of TGF-β1 secreted by bladder cancer cells is encapsulated in exosomes that target healthy fibroblasts and stimulate their differentiation into cancer-associated fibroblasts (CAFs) by triggering SMAD2 phosphorylation [218]. The gene discussed is SMAD2; the disease is urinary bladder cancer.